Abstract
c-Jun, the most extensively studied protein of the activator protein-1 (AP-1) complex, is involved in numerous cell activities, such as proliferation, apoptosis, survival, tumorigenesis and tissue morphogenesis. Earlier studies focused on the structure and function have led to the identification of c-Jun as a basic leucine zipper (bZIP) transcription factor that acts as homo- or heterodimer, binding to DNA and regulating gene transcription. Later on, it was shown that extracellular signals can induce post-translational modifications of c-Jun, resulting in altered transcriptional activity and target gene expression. More recent work has uncovered multiple layers of a complex regulatory scheme in which c-Jun is able to crosstalk, amplify and integrate different signals for tissue development and disease. One example of such scheme is the autocrine amplification loop, in which signal-induced AP-1 activates the c-Jun gene promoter, while increased c-Jun expression feedbacks to potentiate AP-1 activity. Another example of such scheme, based on recent characterization of gene knockout mice, is that c-Jun integrates signals of several developmental pathways, including EGFR-ERK, EGFR-RhoA-ROCK, and activin B-MAP3K1-JNK for embryonic eyelid closure. After more than two decades of extensive research, c-Jun remains at the center stage of a molecular network with mysterious functional properties, some of which are yet to be discovered. In this article, we will provide a brief historical overview of studies on c-Jun regulation and function, and use eyelid development as an example to illustrate the complexity of c-Jun crosstalking with signaling pathways.
Article PDF
Similar content being viewed by others
References
Adler, V., Polotskaya, A., Wagner, F., and Kraft, A.S. (1992). Affinitypurified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem 267, 17001–17005.
Angel, P., Allegretto, E.A., Okino, S.T., Hattori, K., Boyle, W.J., Hunter, T., and Karin, M. (1988a). Oncogene jun encodes a sequencespecific trans-activator similar to AP-1. Nature 332, 166–171.
Angel, P., Hattori, K., Smeal, T., and Karin, M. (1988b). The jun protooncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875–885.
Angel, P., and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072, 129–157.
Atfi, A., Djelloul, S., Chastre, E., Davis, R., and Gespach, C. (1997). Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 272, 1429–1432.
Baker, S.J., Kerppola, T.K., Luk, D., Vandenberg, M.T., Marshak, D. R., Curran, T., and Abate, C. (1992). Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts. Mol Cell Biol 12, 4694–4705.
Behre, G., Whitmarsh, A.J., Coghlan, M.P., Hoang, T., Carpenter, C. L., Zhang, D.E., Davis, R.J., and Tenen, D.G. (1999). c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 274, 4939–4946.
Behrens, A., Jochum, W., Sibilia, M., and Wagner, E.F. (2000). Oncogenic transformation by ras and fos is mediated by c-Jun Nterminal phosphorylation. Oncogene 19, 2657–2663.
Behrens, A., Sibilia, M., and Wagner, E.F. (1999). Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21, 326–329.
Bengal, E., Ransone, L., Scharfmann, R., Dwarki, V.J., Tapscott, S.J., Weintraub, H., and Verma, I.M. (1992). Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68, 507–519.
Biddie, S.C., John, S., Sabo, P.J., Thurman, R.E., Johnson, T.A., Schiltz, R.L., Miranda, T.B., Sung, M.H., Trump, S., Lightman, S.L., et al. (2011). Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell 43, 145–155.
Black, E.J., Street, A.J., and Gillespie, D.A. (1991). Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: correlation with oncogenic activation and deregulated transactivation activity of v-Jun. Oncogene 6, 1949–1958.
Bohmann, D. (1990). Transcription factor phosphorylation: a link between signal transduction and the regulation of gene expression. Cancer Cells 2, 337–344.
Bohmann, D., Bos, T.J., Admon, A., Nishimura, T., Vogt, P.K., and Tjian, R. (1987). Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386–1392.
Bos, T.J., Bohmann, D., Tsuchie, H., Tjian, R., and Vogt, P.K. (1988). v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell 52, 705–712.
Boyle, W.J., Smeal, T., Defize, L.H., Angel, P., Woodgett, J.R., Karin, M., and Hunter, T. (1991). Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64, 573–584.
Chi, H., Sarkisian, M.R., Rakic, P., and Flavell, R.A. (2005). Loss of mitogen-activated protein kinase kinase kinase 4 (MEKK4) results in enhanced apoptosis and defective neural tube development. Proc Natl Acad Sci U S A 102, 3846–3851.
Christerson, L.B., Vanderbilt, C.A., and Cobb, M.H. (1999). MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motil Cytoskeleton 43, 186–198.
Davis, R.J. (1994). MAPKs: new JNK expands the group. Trends Biochem Sci 19, 470–473.
Deak, J.C., and Templeton, D.J. (1997). Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem J 322, 185–192.
Dérijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037.
Devary, Y., Gottlieb, R.A., Lau, L.F., and Karin, M. (1991). Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11, 2804–2811.
Diener, K., Wang, X.S., Chen, C., Meyer, C.F., Keesler, G., Zukowski, M., Tan, T.H., and Yao, Z. (1997). Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc Natl Acad Sci U S A 94, 9687–9692.
Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., et al. (2000). TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071–1083.
Ellenberger, T.E., Brandl, C.J., Struhl, K., and Harrison, S.C. (1992). The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell 71, 1223–1237.
Findlater, G.S., McDougall, R.D., and Kaufman, M.H. (1993). Eyelid development, fusion and subsequent reopening in the mouse. J Anat 183, 121–129.
Florin, L., Hummerich, L., Dittrich, B.T., Kokocinski, F., Wrobel, G., Gack, S., Schorpp-Kistner, M., Werner, S., Hahn, M., Lichter, P., et al. (2004). Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing. Oncogene 23, 7005–7017.
Franklin, C.C., McCulloch, A.V., and Kraft, A.S. (1995). In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem J 305, 967–974.
Franklin, C.C., Sanchez, V., Wagner, F., Woodgett, J.R., and Kraft, A. S. (1992). Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc Natl Acad Sci U S A 89, 7247–7251.
Gage, P.J., Qian, M., Wu, D., and Rosenberg, K.I. (2008). The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev Biol 317, 310–324.
Gallagher, E.D., Gutowski, S., Sternweis, P.C., and Cobb, M.H. (2004). RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279, 1872–1877.
Geh, E., Meng, Q., Mongan, M., Wang, J., Takatori, A., Zheng, Y., Puga, A., Lang, R.A., and Xia, Y. (2011). Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) integrates developmental signals for eyelid closure. Proc Natl Acad Sci USA 108, 17349–17354.
Grose, R. (2003). Epithelial migration: open your eyes to c-Jun. Curr Biol 13, R678–R680.
Guo, Z., Clydesdale, G., Cheng, J., Kim, K., Gan, L., McConkey, D.J., Ullrich, S.E., Zhuang, Y., and Su, B. (2002). Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction. Mol Cell Biol 22, 5761–5768.
Hai, T.W., Liu, F., Allegretto, E.A., Karin, M., and Green, M.R. (1988). A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev 2, 1216–1226.
Haluska, F.G., Huebner, K., Isobe, M., Nishimura, T., Croce, C.M., and Vogt, P.K. (1988). Localization of the human JUN protooncogene to chromosome region 1p31–32. Proc Natl Acad Sci U S A 85, 2215–2218.
Harshman, K.D., Moye-Rowley, W.S., and Parker, C.S. (1988). Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4. Cell 53, 321–330.
Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7, 2135–2148.
Huang, J., Dattilo, L.K., Rajagopal, R., Liu, Y., Kaartinen, V., Mishina, Y., Deng, C.X., Umans, L., Zwijsen, A., Roberts, A.B., et al. (2009). FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate. Development 136, 1741–1750.
Hüser, M., Luckett, J., Chiloeches, A., Mercer, K., Iwobi, M., Giblett, S., Sun, X.M., Brown, J., Marais, R., and Pritchard, C. (2001). MEK kinase activity is not necessary for Raf-1 function. EMBO J 20, 1940–1951.
Johnson, G.L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911–1912.
Johnson, R.S., van Lingen, B., Papaioannou, V.E., and Spiegelman, B.M. (1993). A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 7, 1309–1317.
Karin, M. (1991). Signal transduction and gene control. Curr Opin Cell Biol 3, 467–473.
Karin, M., Liu, Z., and Zandi, E. (1997). AP-1 function and regulation. Curr Opin Cell Biol 9, 240–246.
Kuan, C.Y., Yang, D.D., Samanta Roy, D.R., Davis, R.J., Rakic, P., and Flavell, R.A. (1999). The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667–676.
Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, J., and Woodgett, J.R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156–160.
Lamph, W.W., Wamsley, P., Sassone-Corsi, P., and Verma, I.M. (1988). Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334, 629–631.
Landschulz, W.H., Johnson, P.F., and McKnight, S.L. (1988). The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759–1764.
Lange-Carter, C.A., Pleiman, C.M., Gardner, A.M., Blumer, K.J., and Johnson, G.L. (1993). A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260, 315–319.
Lee, W., Mitchell, P., and Tjian, R. (1987). Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741–752.
Li, G., Gustafson-Brown, C., Hanks, S.K., Nason, K., Arbeit, J.M., Pogliano, K., Wisdom, R.M., and Johnson, R.S. (2003). c-Jun is essential for organization of the epidermal leading edge. Dev Cell 4, 865–877.
Li, M., Ge, Q., Wang, W., Wang, J., and Lu, Z. (2011). c-Jun binding site identification in K562 cells. J Genetics Genomics (Yi chuan xue bao) 38, 235–242.
Lin, A., Frost, J., Deng, T., Smeal, T., al-Alawi, N., Kikkawa, U., Hunter, T., Brenner, D., and Karin, M. (1992). Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 70, 777–789.
Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L., and Karin, M. (1995). Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268, 286–290.
Luetteke, N.C., Qiu, T.H., Peiffer, R.L., Oliver, P., Smithies, O., and Lee, D.C. (1993). TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73, 263–278.
Maki, Y., Bos, T.J., Davis, C., Starbuck, M., and Vogt, P.K. (1987). Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci U S A 84, 2848–2852.
McHenry, J.Z., Leon, A., Matthaei, K.I., and Cohen, D.R. (1998). Overexpression of fra-2 in transgenic mice perturbs normal eye development. Oncogene 17, 1131–1140.
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R.J., Johnson, G.L., and Karin, M. (1994). Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266, 1719–1723.
Mine, N., Iwamoto, R., and Mekada, E. (2005). HB-EGF promotes epithelial cell migration in eyelid development. Development 132, 4317–4326.
Mordret, G. (1993). MAP kinase kinase: a node connecting multiple pathways. Biology of the cell / under the auspices of the European Cell Biology Organization 79, 193–207.
Nakamura, T., Datta, R., Kharbanda, S., and Kufe, D. (1991). Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor. Cell Growth Differ 2, 267–272.
Naoe, H., Araki, K., Nagano, O., Kobayashi, Y., Ishizawa, J., Chiyoda, T., Shimizu, T., Yamamura, K., Sasaki, Y., Saya, H., et al. (2010). The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation. Mol Cell Biol 30, 3994–4005.
Nikolakaki, E., Coffer, P.J., Hemelsoet, R., Woodgett, J.R., and Defize, L.H. (1993). Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 8, 833–840.
Papavassiliou, A.G., Chavrier, C., and Bohmann, D. (1992). Phosphorylation state and DNA-binding activity of c-Jun depend on the intracellular concentration of binding sites. Proc Natl Acad Sci U S A 89, 11562–11565.
Pertovaara, L., Sistonen, L., Bos, T.J., Vogt, P.K., Keski-Oja, J., and Alitalo, K. (1989). Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol 9, 1255–1262.
Pomérance, M., Multon, M.C., Parker, F., Venot, C., Blondeau, J.P., Tocqué, B., and Schweighoffer, F. (1998). Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor. J Biol Chem 273, 24301–24304.
Providence, K.M., and Higgins, P.J. (2004). PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J Cell Physiol 200, 297–308.
Quantin, B., and Breathnach, R. (1988). Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature 334, 538–539.
Rauscher, F.J. 3rd, Cohen, D.R., Curran, T., Bos, T.J., Vogt, P.K., Bohmann, D., Tjian, R., and Franza, B.R. Jr. (1988a). Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240, 1010–1016.
Rauscher, F.J. 3rd, Voulalas, P.J., Franza, B.R. Jr, and Curran, T. (1988b). Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev 2, 1687–1699.
Ryder, K., Lau, L.F., and Nathans, D. (1988). A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci U S A 85, 1487–1491.
Ryder, K., and Nathans, D. (1988). Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A 85, 8464–8467.
Schlesinger, T.K., Fanger, G.R., Yujiri, T., and Johnson, G.L. (1998). The TAO of MEKK. Front Biosci 3, D1181–D1186.
Schumacher, M.A., Goodman, R.H., and Brennan, R.G. (2000). The structure of a CREB bZIP.somatostatin CRE complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding. J Biol Chem 275, 35242–35247.
Shaulian, E., and Karin, M. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol 4, E131–E136.
Sherman, M.L., Stone, R.M., Datta, R., Bernstein, S.H., and Kufe, D. W. (1990). Transcriptional and post-transcriptional regulation of cjun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem 265, 3320–3323.
Short, N.J. (1987). Regulation of transcription. Are some controlling factors more equal than others? Nature 326, 740–741.
Siow, Y.L., Kalmar, G.B., Sanghera, J.S., Tai, G., Oh, S.S., and Pelech, S.L. (1997). Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C. J Biol Chem 272, 7586–7594.
Smeal, T., Binetruy, B., Mercola, D., Grover-Bardwick, A., Heidecker, G., Rapp, U.R., and Karin, M. (1992). Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 12, 3507–3513.
Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M., and Karin, M. (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494–496.
Soh, J.W., Mao, Y., Liu, L., Thompson, W.J., Pamukcu, R., and Weinstein, I.B. (2001). Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J Biol Chem 276, 16406–16410.
Su, Y.C., Han, J., Xu, S., Cobb, M., and Skolnik, E.Y. (1997). NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J 16, 1279–1290.
Sutherland, C., Renaux, B.S., McKay, D.J., and Walsh, M.P. (1994). Phosphorylation of caldesmon by smooth-muscle casein kinase II. J Muscle Res Cell Motil 15, 440–456.
Takatori, A., Geh, E., Chen, L., Zhang, L., Meller, J., and Xia, Y. (2008). Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development 135, 23–32.
Thumkeo, D., Shimizu, Y., Sakamoto, S., Yamada, S., and Narumiya, S. (2005). ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells 10, 825–834.
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., and Ichijo, H. (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2, 222–228.
Toda, T., Shimanuki, M., and Yanagida, M. (1991). Fission yeast genes that confer resistance to staurosporine encode an AP-1-like transcription factor and a protein kinase related to the mammalian ERK1/MAP2 and budding yeast FUS3 and KSS1 kinases. Genes Dev 5, 60–73.
Uda, M., Ottolenghi, C., Crisponi, L., Garcia, J.E., Deiana, M., Kimber, W., Forabosco, A., Cao, A., Schlessinger, D., and Pilia, G. (2004). Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13, 1171–1181.
Wagner, E.F., Schonthaler, H.B., Guinea-Viniegra, J., and Tschachler, E. (2010). Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6, 704–714.
Wolter, S., Doerrie, A., Weber, A., Schneider, H., Hoffmann, E., von der Ohe, J., Bakiri, L., Wagner, E.F., Resch, K., and Kracht, M. (2008). c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol 28, 4407–4423.
Xia, Y., Wu, Z., Su, B., Murray, B., and Karin, M. (1998). JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev 12, 3369–3381.
Xu, S., Robbins, D.J., Christerson, L.B., English, J.M., Vanderbilt, C. A., and Cobb, M.H. (1996). Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain. Proc Natl Acad Sci U S A 93, 5291–5295.
Yan, M., Dai, T., Deak, J.C., Kyriakis, J.M., Zon, L.I., Woodgett, J.R., and Templeton, D.J. (1994). Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372, 798–800.
Yang, J., Boerm, M., McCarty, M., Bucana, C., Fidler, I.J., Zhuang, Y., and Su, B. (2000). Mekk3 is essential for early embryonic cardiovascular development. Nat Genet 24, 309–313.
Yu, Z., Bhandari, A., Mannik, J., Pham, T., Xu, X., and Andersen, B. (2008). Grainyhead-like factor Get1/Grhl3 regulates formation of the epidermal leading edge during eyelid closure. Dev Biol 319, 56–67.
Yujiri, T., Ware, M., Widmann, C., Oyer, R., Russell, D., Chan, E., Zaitsu, Y., Clarke, P., Tyler, K., Oka, Y., et al. (2000). MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A 97, 7272–7277.
Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., and Wagner, E.F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev Cell 4, 879–889.
Zhang, L., Deng, M., Parthasarathy, R., Wang, L., Mongan, M., Molkentin, J.D., Zheng, Y., and Xia, Y. (2005). MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25, 60–65.
Zhang, L., Wang, W., Hayashi, Y., Jester, J.V., Birk, D.E., Gao, M., Liu, C.Y., Kao, W.W., Karin, M., and Xia, Y. (2003). A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J 22, 4443–4454.
Zhang, Y., Neo, S.Y., Wang, X., Han, J., and Lin, S.C. (1999). Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem 274, 35247–35254.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meng, Q., Xia, Y. c-Jun, at the crossroad of the signaling network. Protein Cell 2, 889–898 (2011). https://doi.org/10.1007/s13238-011-1113-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13238-011-1113-3